Friday, September 18, 2009

Consider CombinatoRx (NASDAQ:CRXX), my man

CombinatoRx has a nice pipeline

Currently trading at $2.22 and they are getting FDA committee review on 9/23. Check out what's being said on Stock Rants about them.

No comments:

Post a Comment